| First Author | Jones CL | Year | 2018 |
| Journal | Cancer Cell | Volume | 34 |
| Issue | 5 | Pages | 724-740.e4 |
| PubMed ID | 30423294 | Mgi Jnum | J:355269 |
| Mgi Id | MGI:6256924 | Doi | 10.1016/j.ccell.2018.10.005 |
| Citation | Jones CL, et al. (2018) Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells. Cancer Cell 34(5):724-740.e4 |
| abstractText | In this study we interrogated the metabolome of human acute myeloid leukemia (AML) stem cells to elucidate properties relevant to therapeutic intervention. We demonstrate that amino acid uptake, steady-state levels, and catabolism are all elevated in the leukemia stem cell (LSC) population. Furthermore, LSCs isolated from de novo AML patients are uniquely reliant on amino acid metabolism for oxidative phosphorylation and survival. Pharmacological inhibition of amino acid metabolism reduces oxidative phosphorylation and induces cell death. In contrast, LSCs obtained from relapsed AML patients are not reliant on amino acid metabolism due to their ability to compensate through increased fatty acid metabolism. These findings indicate that clinically relevant eradication of LSCs can be achieved with drugs that target LSC metabolic vulnerabilities. |
